It is a pharma private limited company based in Amritsar, Punjab, India, established in 2015.
2015 | Amritsar, Punjab, India | ActiveNeomac Pharmaceuticals Private Limited, a active private limited company, was established on 10 April 2015 in Amritsar, Punjab, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232PB2015PTC039375. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 49 professional, Its leadership includes Naresh Mahajan (Director), Sahil Mahajan (Director), Mohd Yaqub Mir (Director). Past directors included Kavita Mahajan, Sahil Mahajan. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Second Floor, 12-Preet Vihar, Circular Road, Opp. Lakhanpal Axran,, Amritsar, Punjab, 143001.
U24232PB2015PTC039375
039375
10 April 2015
₹1.00 M
₹0.10 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Neomac Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Naresh Mahajan | Director | 10 Apr 2015 | Current |
| Sahil Mahajan | Director | 28 Aug 2019 | Current |
| Mohd Yaqub Mir | Director | 10 Apr 2015 | Current |
| Shabir Ahmad Bhat | Director | 10 Apr 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jul 2015 | Past |
| Pramod Abcsdd | Director | 31 Jul 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neomac Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 49.32% increase. The company also saw a slight decrease in profitability, with a 8.88% decrease in profit. The company's net worth Soared by an impressive increase of 15.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Neomac Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Neomac Pharmaceuticals has a workforce of 49 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Neomac Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neomac Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Neomac Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
Neomac Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was recorded as a recent event.
Progress on Sahil Mahajan was appointed as a Director was appointed as a Director on 28 Aug 2019 & has been associated with this company since 6 years 3 months . was documented.
Progress on Naresh Mahajan was appointed as a Director was appointed as a Director on 10 Apr 2015 & has been associated with this company since 10 years 7 months . was documented.
The activity Mohd Yaqub Mir was appointed as a Director was appointed as a Director on 10 Apr 2015 & has been associated with this company since 10 years 7 months . was completed.
The activity Shabir Ahmad Bhat was appointed as a Director was appointed as a Director on 10 Apr 2015 & has been associated with this company since 10 years 7 months . was completed.
The CIN of Neomac Pharmaceuticals Private Limited is U24232PB2015PTC039375.
Neomac Pharmaceuticals Private Limited is headquartered at Second Floor, 12-Preet Vihar, Circular Road, Opp. Lakhanpal Axran,, Amritsar, Punjab, 143001.
Neomac Pharmaceuticals Private Limited was incorporated on 10 April 2015.
The current directors of Neomac Pharmaceuticals Private Limited are
The primary industry of Neomac Pharmaceuticals Private Limited is Manufacturing.
Neomac Pharmaceuticals Private Limited is unlisted.
The authorized capital of Neomac Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Neomac Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX